You just read:

SELLAS™ Life Sciences Announces Upcoming Presentation of Phase 2 Clinical Results for WT1 Cancer Vaccine at the 2016 ASCO Annual Meeting

News provided by

SELLAS Life Sciences Group

24 May, 2016, 08:00 ET